Cas:1513-60-6 ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate manufacturer & supplier

Chemical Name:ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate

CAS.NO:1513-60-6

Synonyms:MFCD00041517;PC3289G;4,4,4-Trifluor-3-trifluormethylcrotonsaeure-ethylester;ethyl 4,4,4-trifluoro-3-trifluoromethyl-2-butenoate

Molecular Formula:C₇H₆F₆O₂

Molecular Weight:236.11200

HS Code:2916190090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:128 °C

Density:>1.1

Index of Refraction:1.341

PSA:26.30000

Exact Mass:236.02700

LogP:2.60050

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:3272

Packing Group:

Contact us for information like MFCD00041517 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 4,4,4-trifluoro-3-trifluoromethyl-2-butenoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 4,4,4-trifluoro-3-trifluoromethyl-2-butenoate Use and application,MFCD00041517 technical grade,usp/ep/jp grade.

Related News: As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate manufacturer After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate supplier US citizens who have been to China in the last 14 days need to re-book to one of seven gateway airports: John F. Kennedy International Airport in New York, Los Angeles International Airport, Seattle, San Francisco International Airport, Chicago, Atlanta and Honolulu. ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate vendor As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate factory After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.